STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.

Seung Joon LeeHannah YangWoo Ram KimYu Seong LeeWon Suk LeeSo Jung KongHye Jin LeeJeong Hun KimJaekyung CheonBeodeul KangHong Jae Chon Joo Hoon Kim

Published in: Journal for immunotherapy of cancer (2022)

STING activation can normalize the peritoneal vascular and immune microenvironment, providing a rationale for a novel combination therapeutic strategy for peritoneal carcinomatosis in colon cancer.

Keyphrases

stem cells
clinical trial